MBS Satellite Thermal Cycler from Thermo Scientific
...mates LC microfractionaction, spotting and prepara...LC eluent can be accurately and continuously spott... Matrix solutions can be added automatically. This... for MALDI-TOF-MS measurements. By using it in con...
CQCS kit for etra KR 4i from Thermo Scientific
...s a microprocessor controlled, high speed filter w...lly smooth operation make the Lambda 10-2 ideal fo...roscopy, ratio imaging, spectrophotometry, visual ... accurate aperture positioning. The Lambda 10-2 co...
Biology Products:(Date:11/24/2009)...November24/PRNewswire-FirstCall/--deCODE,genetics,...fits,"firstday"motionsbytheU.S.BankruptcyCourtfort...lastweekfiledavoluntarypetitionfor,reliefunderChap...ptcyCourt. , TheordersissuedbytheBankruptcyCo...uringtheChapter11proceedings.Inparticular,the,comp...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq:...ngandcommercializingnovelpainmanagementtherapies,a...xecutiveOfficer,isscheduledtopresentatthe21stAnnua...1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork. ...Officer,willbeavailabletorespondtoquestionsduringt...
(Date:11/24/2009)...ewswire/--BlueMarbleEnergyCorp.announcedtodaythatt...DA)wererecentlyawarded$2millionbyWashingtonState,s...te/publicpartnershiptoconstructthestate,sfirstspec..., "Thisinvestmentwillsignificantlyspeedthedevelop...lnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."Wea...
(Date:11/24/2009)...pointhasbeenmetforpatientswithadvanced-stage,orrec...PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ: ...calcompanyfocusedonendocrinetherapyandoncology,tod...hitstargetedcytotoxicpeptideconjugate,AEZS-108(for...metrialcancer.Inapersonalizedhealthcareapproach,th...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4